These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 6326308)

  • 21. Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage.
    Toback AC; Sassa S; Poh-Fitzpatrick MB; Schechter J; Zaider E; Harber LC; Kappas A
    N Engl J Med; 1987 Mar; 316(11):645-50. PubMed ID: 3821794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.
    Doss MO
    Eur J Clin Invest; 1989 Feb; 19(1):20-5. PubMed ID: 2499457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary uroporphyrinogen decarboxylase deficiency in porphyria cutanea tarda caused by hormonal contraceptives].
    Doss M
    Dtsch Med Wochenschr; 1983 Dec; 108(48):1857-8. PubMed ID: 6641540
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
    Held JL; Sassa S; Kappas A; Harber LC
    J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
    D'Alessandro Gandolfo L; Griso D; Macri A; Biolcati G; Topi GC
    Dermatologica; 1989; 178(4):206-8. PubMed ID: 2767288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)].
    von Tiepermann R; Doss M
    J Clin Chem Clin Biochem; 1978 Sep; 16(9):513-7. PubMed ID: 712342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.
    Sweeney GD
    Clin Biochem; 1986 Feb; 19(1):3-15. PubMed ID: 3513989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of familial porphyria cutanea tarda.
    Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
    J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria.
    von Tiepermann R; Koss G; Doss M
    Hoppe Seylers Z Physiol Chem; 1980 Aug; 361(8):1217-22. PubMed ID: 7409755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porphyria cutanea tarda.
    Pimstone NR
    Semin Liver Dis; 1982 May; 2(2):132-42. PubMed ID: 6753163
    [No Abstract]   [Full Text] [Related]  

  • 37. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
    Garey JR; Harrison LM; Franklin KF; Metcalf KM; Radisky ES; Kushner JP
    J Clin Invest; 1990 Nov; 86(5):1416-22. PubMed ID: 2243121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepato-erythrocytic porphyria in 2 female twins].
    Sfar Z; Kamoun MR; Kastally R; De Verneuil H; Nordmann Y
    Ann Dermatol Venereol; 1985; 112(5):453-6. PubMed ID: 4041155
    [No Abstract]   [Full Text] [Related]  

  • 39. Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
    de Verneuil H; Grandchamp B; Beaumont C; Picat C; Nordmann Y
    Science; 1986 Nov; 234(4777):732-4. PubMed ID: 3775362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.